{"symbol": "TWST", "companyName": "Twist Bioscience Corp", "exchange": "NASDAQ/NGS (GLOBAL SELECT MARKET)", "industry": "Research and Development in Biotechnology ", "website": "www.twistbioscience.com", "description": "Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by 'writing' DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.", "CEO": "Emily Leproust", "securityName": "Twist Bioscience Corp", "issueType": "cs", "sector": "Professional, Scientific, and Technical Services", "primarySicCode": 2836, "employees": 525, "tags": ["Health Technology", "Biotechnology"], "address": "681 Gateway Blvd.", "address2": null, "state": "California", "city": "South San Francisco", "zip": "94080", "country": "US", "phone": "18007190671"}